Humasis

Humasis is a South Korean public in vitro diagnostics and medical device company focused on point-of-care testing and rapid immunodiagnostic products. Founded in 2000, the company develops and manufactures lateral-flow and instrument-assisted diagnostic kits spanning infectious diseases, women’s health, cardiac markers, cancer markers, and wellness testing. Its commercial portfolio includes COVID-19 and COVID-19/Flu combo antigen tests, pregnancy and ovulation tests, and quantitative POCT analyzer systems such as HUBI-QUAN Pro and HUBI-TAS. The company also develops biomaterials and digital health-related solutions that support disease management, remote diagnostics, and integration with LIS/HIS systems. Humasis exports globally and positions itself as an R&D-driven diagnostics company rather than a therapeutic drug developer.